This inventor holds 1 USPTO granted patent. Top assignee: Azura Ophthalmics Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hadas Rapaport and Ophthalmic Innovation.
Introduction
Hadas Rapaport is an inventor associated with Zofar, Israel, and Azura Ophthalmics Ltd. Her patent work addresses a treatment approach for Demodex and related disorders around the eye.
Latest Patents
Rapaport is credited with 1 patent: “Metered Dose for Demodex and Disorders Related Thereto.” The patent describes pharmaceutical compositions and methods for treating Demodex or related disorders around the eye by applying a metered dose of a semi-solid product from a product tube.
Career Highlights
Rapaport’s listed invention focuses on delivering ophthalmic treatment in a measured dose. The patent connects her work with Azura Ophthalmics Ltd., a company working in the ophthalmic field.
Collaborations
Her listed coworkers include Omer Rafaeli and Charles Bosworth. Their names provide context for the professional network associated with her work.
Conclusion
Hadas Rapaport’s patent centers on a metered-dose approach to treating Demodex and related disorders around the eye, reflecting her contribution to ophthalmic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile